These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33942023)

  • 1. Analysis of SARS-CoV-2 antibodies from dried blood spot samples with the Roche Elecsys Immunochemistry method.
    Fontaine E; Saez C
    Pract Lab Med; 2021 May; 25():e00234. PubMed ID: 33942023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of dried blood spot samples for SARS-CoV-2 antibody detection using the Roche Elecsys ® high throughput immunoassay.
    Mulchandani R; Brown B; Brooks T; Semper A; Machin N; Linley E; Borrow R; Wyllie D;
    J Clin Virol; 2021 Mar; 136():104739. PubMed ID: 33588354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dried blood spot protocol for high throughput analysis of SARS-CoV-2 serology based on the Roche Elecsys anti-N assay.
    Beyerl J; Rubio-Acero R; Castelletti N; Paunovic I; Kroidl I; Khan ZN; Bakuli A; Tautz A; Oft J; Hoelscher M; Wieser A;
    EBioMedicine; 2021 Aug; 70():103502. PubMed ID: 34333234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analytical and Clinical Evaluation of the Automated Elecsys Anti-SARS-CoV-2 Antibody Assay on the Roche cobas e602 Analyzer.
    Chan CW; Parker K; Tesic V; Baldwin A; Tang NY; van Wijk XMR; Yeo KJ
    Am J Clin Pathol; 2020 Oct; 154(5):620-626. PubMed ID: 32814955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remote Fingerstick Blood Collection for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Testing.
    Garcia-Beltran WF; Miller TE; Kirkpatrick G; Nixon A; Astudillo MG; Yang D; Mahanta LM; Murali M; Dighe AS; Lennerz J; Thierauf J; Naranbhai V; Iafrate AJ
    Arch Pathol Lab Med; 2021 Apr; 145(4):415-418. PubMed ID: 33264390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Head-to-head comparison of two rapid high-throughput automated electrochemiluminescence immunoassays targeting total antibodies to the SARS-CoV-2 nucleoprotein and spike protein receptor binding domain.
    Poljak M; Oštrbenk Valenčak A; Štamol T; Seme K
    J Clin Virol; 2021 Apr; 137():104784. PubMed ID: 33711693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicentre Performance Evaluation of the Elecsys Anti-SARS-CoV-2 Immunoassay as an Aid in Determining Previous Exposure to SARS-CoV-2.
    Riester E; Majchrzak M; Mühlbacher A; Tinguely C; Findeisen P; Hegel JK; Laimighofer M; Rank CM; Schönfeld K; Langen F; Laengin T; Niederhauser C
    Infect Dis Ther; 2021 Dec; 10(4):2381-2397. PubMed ID: 34368915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative performance data for multiplex SARS-CoV-2 serological assays from a large panel of dried blood spot specimens.
    Cholette F; Fabia R; Harris A; Ellis H; Cachero K; Schroeder L; Mesa C; Lacap P; Arnold C; Galipeau Y; Langlois MA; Colwill K; Gingras AC; McGeer A; Giles E; Day J; Osiowy C; Durocher Y; Hankins C; Mazer B; Drebot M; Kim J;
    Heliyon; 2022 Sep; 8(9):e10270. PubMed ID: 36060461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Validation of the Elecsys Anti-SARS-CoV-2 Immunoassay as a Highly Specific Tool for Determining Past Exposure to SARS-CoV-2.
    Muench P; Jochum S; Wenderoth V; Ofenloch-Haehnle B; Hombach M; Strobl M; Sadlowski H; Sachse C; Torriani G; Eckerle I; Riedel A
    J Clin Microbiol; 2020 Sep; 58(10):. PubMed ID: 32747400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of dried blood spots as alternative sampling material for serological detection of anti-SARS-CoV-2 antibodies using established ELISAs.
    Weisser H; Steinhagen K; Höcker R; Borchardt-Lohölter V; Anvari Ö; Kern PM
    Clin Chem Lab Med; 2021 Apr; 59(5):979-985. PubMed ID: 33554537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Dried Blood Spots and Venous Blood for the Detection of SARS-CoV-2 Antibodies in a Population of Nursing Home Residents.
    Meyers E; Heytens S; Formukong A; Vercruysse H; De Sutter A; Geens T; Hofkens K; Janssens H; Nys E; Padalko E; Deschepper E; Cools P
    Microbiol Spectr; 2021 Oct; 9(2):e0017821. PubMed ID: 34549995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity testing by point prevalence as a simple assessment strategy using the Roche Elecsys® anti-SARS-CoV-2 immunoassay.
    Kittel M; Findeisen P; Muth MC; Thiaucourt M; Gerhards C; Neumaier M; Haselmann V
    Int J Infect Dis; 2021 Apr; 105():632-638. PubMed ID: 33578017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical performance of the Roche Elecsys SARS-CoV-2 antigen fully automated electrochemiluminescence immunoassay.
    Salvagno GL; Pighi L; De Nitto S; Lippi G
    Pract Lab Med; 2022 Mar; 29():e00265. PubMed ID: 35071720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays.
    Allen N; Brady M; Carrion Martin AI; Domegan L; Walsh C; Houlihan E; Kerr C; Doherty L; King J; Doheny M; Griffin D; Molloy M; Dunne J; Crowley V; Holmes P; Keogh E; Naughton S; Kelly M; O'Rourke F; Lynagh Y; Crowley B; de Gascun C; Holder P; Bergin C; Fleming C; Ni Riain U; Conlon N;
    Microbiol Spectr; 2021 Oct; 9(2):e0039121. PubMed ID: 34585976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Antibody Binding and Neutralization in Dried Blood Spot Eluates and Paired Plasma.
    Itell HL; Weight H; Fish CS; Logue JK; Franko N; Wolf CR; McCulloch DJ; Galloway J; Matsen FA; Chu HY; Overbaugh J
    Microbiol Spectr; 2021 Oct; 9(2):e0129821. PubMed ID: 34668728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical and Clinical Evaluation of the Semiquantitative Elecsys Anti-SARS-CoV-2 Spike Protein Receptor Binding Domain Antibody Assay on the Roche cobas e602 Analyzer.
    Chan CW; Yi X; Lenza M; Baldwin AD; Jakalski J; Tesic V; Yeo KJ
    Am J Clin Pathol; 2022 Jan; 157(1):109-118. PubMed ID: 34463315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Throughput Multiplex SARS-CoV-2 IgG Microsphere Immunoassay for Dried Blood Spots: A Public Health Strategy for Enhanced Serosurvey Capacity.
    Styer LM; Hoen R; Rock J; Yauney E; Nemeth K; Bievenue R; Parker MM
    Microbiol Spectr; 2021 Sep; 9(1):e0013421. PubMed ID: 34319133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and Validation of the Roche Elecsys SARS-CoV-2 Antigen Electro-Chemiluminescent Immunoassay in a Southeast Asian Region.
    Lau CS; Phua SK; Hoo SP; Jiang B; Aw TC
    Vaccines (Basel); 2022 Jan; 10(2):. PubMed ID: 35214657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High seroprevalence for SARS-CoV-2 among household members of essential workers detected using a dried blood spot assay.
    McDade TW; McNally EM; Zelikovich AS; D'Aquila R; Mustanski B; Miller A; Vaught LA; Reiser NL; Bogdanovic E; Fallon KS; Demonbreun AR
    PLoS One; 2020; 15(8):e0237833. PubMed ID: 32797108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Two Automated Immunoassays for the Detection of SARS-CoV-2 Nucleocapsid Antibodies.
    Hubbard JA; Geno KA; Khan J; Szczepiorkowski ZM; de Gijsel D; Ovalle AA; AlSalman AS; Gallagher TL; Johnston AA; Tibbetts AR; Vital SE; Cervinski MA; Nerenz RD
    J Appl Lab Med; 2021 Mar; 6(2):429-440. PubMed ID: 32976593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.